Difference between revisions of "Uy GL, et al. Blood (2012) cited as Ref 630 in DOI: 10.1038/s41392-020-0110-5 (Q9893)"

From Wikibase.slis.ua.edu
Jump to navigation Jump to search
(‎Created claim: Published In Name String (P102): Blood, #quickstatements; #temporary_batch_1590006349955)
(‎Created claim: Page(s) (P105): 3917-3924, #quickstatements; #temporary_batch_1590074839150)
 
(2 intermediate revisions by the same user not shown)
Property / Volume
 +
119
Property / Volume: 119 / rank
 +
Normal rank
Property / title
 +
A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia (English)
Property / title: A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia (English) / rank
 +
Normal rank
Property / Page(s)
 +
3917-3924
Property / Page(s): 3917-3924 / rank
 +
Normal rank

Latest revision as of 15:47, 21 May 2020

Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language Label Description Also known as
English
Uy GL, et al. Blood (2012) cited as Ref 630 in DOI: 10.1038/s41392-020-0110-5
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8

    Statements

    Uy GL
    0 references
    0 references
    2012
    0 references
    Blood
    0 references
    119
    0 references
    A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia (English)
    0 references
    3917-3924
    0 references